ES532150A0 - Procedimiento para la preparacion de nuevos eteres triciclicos - Google Patents
Procedimiento para la preparacion de nuevos eteres triciclicosInfo
- Publication number
- ES532150A0 ES532150A0 ES532150A ES532150A ES532150A0 ES 532150 A0 ES532150 A0 ES 532150A0 ES 532150 A ES532150 A ES 532150A ES 532150 A ES532150 A ES 532150A ES 532150 A0 ES532150 A0 ES 532150A0
- Authority
- ES
- Spain
- Prior art keywords
- eters
- procedure
- preparation
- new tricyclic
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Detergent Compositions (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH240283 | 1983-05-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES532150A0 true ES532150A0 (es) | 1986-02-01 |
| ES8604211A1 ES8604211A1 (es) | 1986-02-01 |
Family
ID=4232950
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES532150A Expired ES8604211A1 (es) | 1983-05-03 | 1984-05-03 | Procedimiento para la preparacion de nuevos eteres triciclicos |
| ES545146A Expired ES8603869A1 (es) | 1983-05-03 | 1985-07-12 | Procedimiento para la preparacion de nuevos eteres tricicli-cos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES545146A Expired ES8603869A1 (es) | 1983-05-03 | 1985-07-12 | Procedimiento para la preparacion de nuevos eteres tricicli-cos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4560693A (es) |
| EP (1) | EP0127763B1 (es) |
| JP (1) | JPS59206386A (es) |
| KR (1) | KR840009106A (es) |
| AT (1) | ATE49764T1 (es) |
| AU (1) | AU2750184A (es) |
| DE (1) | DE3481126D1 (es) |
| DK (1) | DK217284A (es) |
| ES (2) | ES8604211A1 (es) |
| FI (1) | FI841758A (es) |
| GR (1) | GR79850B (es) |
| HU (3) | HU191757B (es) |
| IL (1) | IL71665A (es) |
| NO (1) | NO841755L (es) |
| NZ (1) | NZ208024A (es) |
| PT (1) | PT78519B (es) |
| ZA (1) | ZA843287B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW4585A1 (en) * | 1984-04-19 | 1985-11-20 | Hoffmann La Roche | Imidazole derivatives |
| IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| EP0204215B1 (en) | 1985-05-24 | 1993-08-11 | G.D. Searle & Co. | 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
| AU3690289A (en) * | 1988-05-25 | 1989-12-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
| AT391693B (de) * | 1988-11-15 | 1990-11-12 | Cl Pharma | Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer |
| US5395952A (en) * | 1991-06-03 | 1995-03-07 | Sumitomo Chemical Company, Limited | Benzimidazole derivatives agricultural and horticultural fungicides containing the same as an active ingredient and intermediate compounds thereof |
| NZ242756A (en) * | 1991-06-03 | 1994-07-26 | Sumitomo Chemical Co | Benzimidazole derivatives having a fused ring which contains 1 or 2 o atoms and at least 1 -cf2- unit; use as fungicides; and precursors |
| DE4139950A1 (de) * | 1991-12-04 | 1993-06-09 | Bayer Ag, 5090 Leverkusen, De | 2-cyanobenzimidazole, ein verfahren zu ihrer herstellung und ihre verwendung und neue vorprodukte |
| US5472974A (en) * | 1992-02-26 | 1995-12-05 | Sumitomo Chemical Company, Limited | Benzimidazole derivatives, agricultural and horticultural fungicides containing the same as an active ingredient and intermediate compounds thereof |
| RU2154062C2 (ru) * | 1993-06-29 | 2000-08-10 | Бик Гульден Ломберг Хемише Фабрик Гмбх. | Замещенные арилтиоалкилтиопиридины, способ их получения, лекарственное средство на их основе и способ получения лекарственного средства. |
| AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
| PL181801B1 (pl) * | 1994-06-10 | 2001-09-28 | Byk Gulden Lomberg Chem Fab | Podstawione aryloalkilotioalkilotiopirydyny do zwalczania bakterii Helicobacter oraz srodek leczniczy zawierajacy podstawione aryloalkilotioalkilotiopirydyny PL |
| PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
| US6297236B1 (en) | 1998-04-06 | 2001-10-02 | Bayer Aktiengesellschaft | Fungicide active substance combinations |
| DE19745692A1 (de) * | 1997-07-24 | 1999-01-28 | Bayer Ag | Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten |
| US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| CN102140099A (zh) | 2010-02-02 | 2011-08-03 | 山东轩竹医药科技有限公司 | 新的吡啶衍生物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4045564A (en) * | 1974-02-18 | 1977-08-30 | Ab Hassle | Benzimidazole derivatives useful as gastric acid secretion inhibitors |
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| IN148930B (es) * | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
-
1984
- 1984-04-27 HU HU841643A patent/HU191757B/hu unknown
- 1984-04-27 HU HU863795A patent/HU193408B/hu unknown
- 1984-04-27 HU HU841642A patent/HU191756B/hu unknown
- 1984-04-27 IL IL71665A patent/IL71665A/xx not_active IP Right Cessation
- 1984-04-30 AT AT84104831T patent/ATE49764T1/de not_active IP Right Cessation
- 1984-04-30 EP EP84104831A patent/EP0127763B1/de not_active Expired - Lifetime
- 1984-04-30 AU AU27501/84A patent/AU2750184A/en not_active Abandoned
- 1984-04-30 DE DE8484104831T patent/DE3481126D1/de not_active Expired - Fee Related
- 1984-05-01 US US06/606,873 patent/US4560693A/en not_active Expired - Fee Related
- 1984-05-01 DK DK217284A patent/DK217284A/da not_active Application Discontinuation
- 1984-05-02 JP JP59087968A patent/JPS59206386A/ja active Granted
- 1984-05-02 GR GR74558A patent/GR79850B/el unknown
- 1984-05-02 NO NO841755A patent/NO841755L/no unknown
- 1984-05-02 NZ NZ208024A patent/NZ208024A/en unknown
- 1984-05-02 PT PT78519A patent/PT78519B/pt unknown
- 1984-05-03 ES ES532150A patent/ES8604211A1/es not_active Expired
- 1984-05-03 ZA ZA843287A patent/ZA843287B/xx unknown
- 1984-05-03 KR KR1019840002393A patent/KR840009106A/ko not_active Application Discontinuation
- 1984-05-03 FI FI841758A patent/FI841758A/fi not_active Application Discontinuation
-
1985
- 1985-07-12 ES ES545146A patent/ES8603869A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU2750184A (en) | 1984-11-08 |
| IL71665A (en) | 1988-05-31 |
| HU193408B (en) | 1987-10-28 |
| ES8603869A1 (es) | 1986-01-16 |
| HUT34184A (en) | 1985-02-28 |
| HUT34196A (en) | 1985-02-28 |
| IL71665A0 (en) | 1984-07-31 |
| PT78519A (de) | 1984-06-01 |
| JPS59206386A (ja) | 1984-11-22 |
| EP0127763A1 (de) | 1984-12-12 |
| DK217284D0 (da) | 1984-05-01 |
| FI841758A (fi) | 1984-11-04 |
| PT78519B (de) | 1986-07-14 |
| ES8604211A1 (es) | 1986-02-01 |
| GR79850B (es) | 1984-10-31 |
| ZA843287B (en) | 1984-12-24 |
| US4560693A (en) | 1985-12-24 |
| HU191756B (en) | 1987-04-28 |
| FI841758A0 (fi) | 1984-05-03 |
| ES545146A0 (es) | 1986-01-16 |
| JPH0471077B2 (es) | 1992-11-12 |
| DK217284A (da) | 1984-11-04 |
| HU191757B (en) | 1987-04-28 |
| ATE49764T1 (de) | 1990-02-15 |
| NZ208024A (en) | 1987-07-31 |
| DE3481126D1 (de) | 1990-03-01 |
| KR840009106A (ko) | 1984-12-24 |
| NO841755L (no) | 1984-11-05 |
| EP0127763B1 (de) | 1990-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES532150A0 (es) | Procedimiento para la preparacion de nuevos eteres triciclicos | |
| SE8601907L (sv) | Antitrombogena och kardiotoniska imidazokinoliner | |
| ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
| DE3772015D1 (de) | Chinolinverbindung. | |
| FI925848A0 (fi) | Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar | |
| ES2046229T3 (es) | Composicion antiulcerosa. | |
| ATE17327T1 (de) | Phospholipidloesungen. | |
| DE3779187D1 (de) | 2-trifluormethyl-benzimidazole. | |
| IT8620322A0 (it) | Impiego di un perfluoropolietere fluido ad altissima viscosita' come lubrificante. | |
| FI915979A0 (fi) | Fenylalkylaminoalkylfoereningar samt foerfaranden foer deras framstaellning och laekemedel som innehaoller dessa foereningar. | |
| FR2359150A1 (fr) | Derives etain-triorganiques d'oxydes d'hydroxydiazenium utiles comme fongicides | |
| MY101309A (en) | Benzoylureas, and their production and use | |
| ES2051856T3 (es) | Procedimiento para la obtencion de agentes antiarritmicos de 1,2,3,4-tetrahidroisoquinolina. | |
| ES8604133A1 (es) | Procedimiento para la obtencion de nuevos derivados de ben- zoilurea y productos intermedios | |
| ES538155A0 (es) | Procedimiento para la obtencion de un derivado de arganofosfato | |
| FR2378519A1 (es) | ||
| ES547691A0 (es) | Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos | |
| SE8206377D0 (sv) | Nya kelatbildande biskinolinforeningar | |
| ATE18554T1 (de) | Optisch aktive imidazolylpropanol-verbindungen und deren herstellung und anwendung. | |
| FR2362827A1 (fr) | Nouveaux diurethanes utiles comme herbicides | |
| FI905664A (fi) | Glutarsyraderivat och deras framstaellningsfoerfaranden. | |
| ES493044A0 (es) | Un procedimiento para la preparacion de agentes antibacterianos beta-lactanicos. | |
| ES520990A0 (es) | Un procedimiento para preparar 2-piridilalcohilaminas disustituidas en la posicion 3 y 5. | |
| ATE18210T1 (de) | Pyridinderivate, ihre herstellung und verwendung. |